PEN Q3 2024 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$301M+11.1% YoY

Gross Profit

$200M66.5% margin

Operating Income

$35M11.7% margin

Net Income

$30M9.8% margin

EPS (Diluted)

$0.75

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

$56M

Free Cash Flow

$51M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$375M

Stockholders' Equity

$1.1B

Cash & Equivalents

$280M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$301M	$271M	+11.1%
Gross Profit	$200M	$178M	+12.7%
Operating Income	$35M	$13M	+180.1%
Net Income	$30M	$9M	+220.5%

Geographic Segments

UNITED STATES

$226M75%

Other Non-US

$75M25%